At the Department of Ophthalmology, Aarhus University Hospital, Denmark, we perform refractive surgery on several hundred eyes per year for myopia of more than −6 D. Between July and October 2000, patients were invited to participate in a prospective study of PRK and LASIK (Clinical trial identifier NCT00404105). One eye from each of 45 patients was included. Inclusion criteria included spherical equivalent refraction of −6.00 to −8.00 D, regular astigmatism of less than 1.50 D, stable refraction (<0.50 D change) for at least 2 years, and a monocular best spectacle corrected visual acuity (BSCVA) of 0.10 (logMAR units) or better in both eyes. Exclusion criteria included previous ocular disease or eye surgery, young age (<19 years), susceptibility to keloid formation, and pregnancy or breast-feeding.
The study protocol followed the tenets of the Declaration of Helsinki and was approved by the local ethics committee of Aarhus, Denmark. Informed written consent was obtained from all participants after explanation of the nature and possible consequences of the study. Patients were randomized to PRK or LASIK using a random number system. Twenty-five subjects were randomized to LASIK, and 20 to PRK. Retreatments were not allowed within the first year after surgery.